Elbow Arthroplasty: A Concise Literature Update

Total elbow arthroplasty (TEA) is increasingly used, especially in patients with rheumatoid arthritis (RA) and distal humerus fractures (DHFs). This narrative review of the recent literature published in ۲۰۲۲ reached the following conclusions: ۱) Age greater than ۸۰ is not a contraindication for TEA. ۲) The estimated ۱۰-year survival reported for linked TEAs is ۹۲%, and unlinked TEAs ۸۴%. ۳) For DHFs in the elderly, regarding the flexion/extension arc, TEA gives substantially better results than open reduction and internal fixation (ORIF). The reoperation and elbow stiffness rates are substantial ly lower in TEA than in ORIF. ۴) Comparing distal humeral hemiarthroplasty (DHH) vs. TEA in individuals over ۶۵ years with a non-reconstructable DHF favors DHH regarding the range of motion but with a similarly high rate of adverse events in the two surgical techniques. ۵) The rate of eradication of periprosthetic joint infection (PJI) is ۶۹-۷۶% with two-stage, ۷۱% with resection arthroplasty, ۶۷% with one-stage, ۵۸% with DAIR, and ۴۰% with elbow arthrodesis. Level of evidence: III

کلیدواژه ها:

Complications ، distal humeral fractures ، Elbow ، Results ، Rheumatoid arthritis ، Survival ، total elbow arthroplasty